ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
162 hedge funds and large institutions have $873M invested in Achillion Pharmaceuticals, Inc. in 2016 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 44 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
+15
Holders Change %
+10.2%
% of All Funds
4.33%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
25
Increased
57
Reduced
44
Closed
9
Calls
$13M
Puts
$4.38M
Net Calls
+$8.59M
Net Calls Change
+$2.19M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$12.3M |
| 2 |
O
OrbiMed
New York
|
+$11.5M |
| 3 |
PA
Perceptive Advisors
New York
|
+$7.53M |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
+$7.5M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$7.24M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$35.7M |
| 2 |
Millennium Management
New York
|
-$25.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$15.1M |
| 5 |
JPMorgan Chase & Co
New York
|
-$4.9M |
